Characterization of four basic models of indirect pharmacodynamic responses

被引:100
作者
Sharma, A
Jusko, WJ
机构
[1] SUNY BUFFALO, SCH PHARM, DEPT PHARMACEUT, BUFFALO, NY 14260 USA
[2] ROSWELL PK CANC INST, DEPT EXPT THERAPEUT, BUFFALO, NY 14263 USA
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1996年 / 24卷 / 06期
关键词
pharmacodynamics; indirect response models;
D O I
10.1007/BF02353483
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Four basic models of indirect pharmacodynamic responses were characterized in terms of changing dose, I-max or S-max, and IC50 or SC50 to examine the effects of these fundamental drug properties on response profiles. Standard pharmacokinetic parameters were used for generating plasma concentration, and response-time profiles using computer simulations. Comparisons to theoretical expectations were made. In all four models, the maximum response (R-max) (inhibition or stimulation) and the time of its occurrence (T-Rmax) were dependent on the model, dose, I-max or S-max, and IC50 or SC50 values. An increase in dose or a decrease in IC50 or SC50 by the same factor produced, as theoretically expected identical and superimposable pharmacodynamic response patterns in each of the models. Some parameters (T-Rmax, ABEC) were nearly proportional to log dose, while others (R-max, C-Rmax) were nonlinear. Assessment of expected response signature patterns as demonstrated in this report may be helpful in experimental designs and in assigning appropriate models to pharmacodynamic data.
引用
收藏
页码:611 / 635
页数:25
相关论文
共 14 条
[2]   COMPARISON OF 4 BASIC MODELS OF INDIRECT PHARMACODYNAMIC RESPONSES [J].
DAYNEKA, NL ;
GARG, V ;
JUSKO, WJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1993, 21 (04) :457-478
[4]   CONVERGENCE OF DIRECT AND INDIRECT PHARMACODYNAMIC RESPONSE MODELS - RESPONSE [J].
JUSKO, WJ ;
KO, HC ;
EBLING, WF .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1995, 23 (01) :5-8
[5]   PHYSIOLOGICAL INDIRECT RESPONSE MODELS CHARACTERIZE DIVERSE TYPES OF PHARMACODYNAMIC EFFECTS [J].
JUSKO, WJ ;
KO, HC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (04) :406-419
[6]  
KO JC, 1995, PHARMACOTHERAPY, V15, P509
[7]  
KRZYZANSKI W, 1996, UNPUB INTEGRATED FUN
[8]  
KRZYZANSKI W, 1997, IN PRESS J PHARMACOK
[9]   GENDER-BASED EFFECTS ON METHYLPREDNISOLONE PHARMACOKINETICS AND PHARMACODYNAMICS [J].
LEW, KH ;
LUDWIG, EA ;
MILAD, MA ;
DONOVAN, K ;
MIDDLETON, E ;
FERRY, JJ ;
JUSKO, WJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (04) :402-414
[10]   PHARMACODYNAMIC MODEL FOR JOINT EXOGENOUS AND ENDOGENOUS CORTICOSTEROID SUPPRESSION OF LYMPHOCYTE TRAFFICKING [J].
MILAD, MA ;
LUDWIG, EA ;
ANNE, S ;
MIDDLETON, E ;
JUSKO, WJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1994, 22 (06) :469-480